A novel guideline document elaborated by the EU-consortium GoNanoBioMat and presented at the final dissemination event. The GoNanoBioMat framework is designed to elaborate current knowledge to small and medium-sized enterprises (SMEs), their suppliers, service providers and research institutes at the interface of nanomaterials and nanomedicine. The Swiss partners in the consortium were funded by Innosuisse.
Guidelines: Safe-by-design for medicinal polymeric nanocarriers
Related articles
Questions about nanomater...
New initiative to pool know-how on synthetic nanomaterials in Switzerland Hönggerberg, June 7, 2018 – At the Swiss Nano Convention 2018, taking place at ETH Zurich this
Nanomedicine: The Minuten...
Tiny particles that can fight cancer or that can easily pass through any interface within our body are a great promise for medicine. But there is little
Developing trends in nano...
Waste containing nanomaterials — or nanowaste — is an emerging safety concern worldwide, warranting specific environmentally sound waste management and regulation. Authors: Arturo A. Keller, Alex Ehrens, Yuanfang Zheng & Bernd
Nanomedicine in Liverpool
contactpointnano was present at Nanomed Europe 23 in Liverpool (June 19-22). This event is organized by ETPN and it is the largest Nanomedicine event in Europe. The
Clinam Summit in Basel
This year, the 14th European and Global Summit for Clinical Nanomedicine (CLINAM Summit) organized by the European Foundation for Clinical Nanomedicine will take place on 8-11 October
Webinar: Open questions a...
Face masks characterize the public spaces today. Together with other measures, such as social distancing, hand hygiene and contact tracing, masks actively contribute to fight the spread
Characterizing Nanopartic...
Live Webinar, Thursday 19 November, 15:00 (Zürich). Guest speaker Dr. Sandor Balog, Details, Please register for this event using this link
Safe-by-design and EU fun...
Contribution of the EU NanoSafetyCluster (NSC), supporting the SbD-study of the European Commission, March 2021 Editors: Andreas Falk, Flemming R. Cassee and Eva Valsami-Jones
NanoGVA Symposium
The 2nd NanoGVA Symposium “Creating the Invisible: the development of nanomedicines” will be hosted by the University of Geneva on October 5-6, 2023. The symposium will deal
Crucial results for coron...
Empa researcher Peter Wick, Head of the Particles-Biology Interactions Laboratory in St. Gallen and Director of contactpointnano.ch talks to Empa Quarterly about recent antibody studies, which are